Prestige BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '24 Oct 10, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	170,192	103,966	113,582	137,620	396,635	-
Market Cap Growth	-8.47%	-8.47%	-17.47%	-65.30%	-	-
Enterprise Value	122,899	44,042	-6,736	-150,494	-63,944	-
Last Close Price	14160.00	8650.00	9450.00	11450.00	33000.00	-
PE Ratio	-	-15.79	32.32	-3.02	-230.40	-
PS Ratio	150.88	150.88	701.81	-	-	-
PB Ratio	9.69	0.20	0.21	0.32	0.69	-
P/FCF Ratio	-1.53	-1.53	-1.05	-1.34	-24.19	-
P/OCF Ratio	-2.16	-2.16	-1.88	-3.00	-25.68	-
EV/Sales Ratio	178.35	63.91	-41.62	-	-	-
EV/EBITDA Ratio	-0.96	-0.96	-0.53	1.27	3.83	-
EV/EBIT Ratio	-0.71	-0.71	-6.51	1.23	3.48	-
EV/FCF Ratio	-1.80	-0.65	0.06	1.47	3.90	-
Debt / Equity Ratio	0.20	0.20	0.21	0.01	0.01	0.02
Debt / EBITDA Ratio	-	-	9.11	-	-	-
Debt / FCF Ratio	-1.54	-1.54	-1.06	-0.04	-0.47	-0.21
Asset Turnover	0.00	0.00	0.00	-	-	-
Inventory Turnover	0.10	0.10	0.01	-	-	-
Quick Ratio	1.57	1.57	2.24	7.26	32.70	5.71
Current Ratio	1.72	1.72	2.31	7.45	32.74	5.88
Return on Equity (ROE)	-10.38%	-10.38%	-0.59%	-42.08%	-2.07%	-
Return on Assets (ROA)	-5.35%	-5.35%	0.10%	-13.89%	-3.01%	-
Return on Capital (ROIC)	-6.07%	-6.07%	0.12%	-15.08%	-3.18%	-
Earnings Yield	-3.87%	-31.67%	15.47%	-153.65%	-1.86%	-
FCF Yield	-40.01%	-65.49%	-95.65%	-74.36%	-4.13%	-
Buyback Yield / Dilution	-	-	-16.46%	-20.98%	-
Total Shareholder Return	-	-	-16.46%	-20.98%	-

Source: S&P Capital IQ. Standard template. Financial Sources.